Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: A case-control study

Transplantation

Volumn 88, Issue 1, 2009, Pages 83-88

  Manitpisitkul, Wana ^a   Drachenberg, Cinthia ^a   Ramos, Emilio ^a   Munivenkatappa, Raghava ^a   Philosophe, Benjamin ^a   Klassen, David ^a   Haririan, Abdolreza ^a,b  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

BK virus nephropathy; Immunosuppression; Kidney transplantation; Mycophenolate mofetil; Prednisone; Tacrolimus

Indexed keywords

BASILIXIMAB; COTRIMOXAZOLE; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BK VIRUS; BK VIRUS NEPHROPATHY; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG SAFETY; FEMALE; GRAFT DYSFUNCTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY INFECTION; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL; RISK FACTOR; ALLOTRANSPLANTATION; BIOPSY; CHEMICALLY INDUCED DISORDER; KIDNEY TRANSPLANTATION; MIDDLE AGED; PATHOGENICITY; PATHOLOGY; RISK; RISK ASSESSMENT; STATISTICAL MODEL; TIME; VIROLOGY; VIRUS ACTIVATION; VIRUS INFECTION;

BIOPSY; BK VIRUS; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; ODDS RATIO; POLYOMAVIRUS INFECTIONS; PREDNISONE; RISK ASSESSMENT; RISK FACTORS; TACROLIMUS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; VIRUS ACTIVATION;

EID: 67651012057     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181aa8d93     Document Type: Article

References (35)

1. Knowles WA. The epidemiology of BK virus and the occurrence of antigenic and genomic subtypes. In: Khalili K, Stoner GL, eds. Human polyomaviruses: Molecular and clinical perspectives. New York, Wiley-Liss 2001, p 527.
2. Gardner SD, Field AM, Coleman DV, et al. New human papovavirus (B.K.) isolated from the urine after renal transplantation. Lancet 1980; 49: 219.
3. Howell DN, Smith SR, Butterly DW, et al. Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients. Transplantation 1999; 68: 1279.
4. Drachenberg CB, Beskow CO, Cangro CB, et al. Human polyoma virus in renal allograft biopsies; morphological findings and correlation with urine cytology. Hum Pathol 1999; 30: 970.
5. Hirsch HH. Polyomavirus BK nephropathy: A (re-) emerging complication in renal transplantation. Am J Transplant 2002; 2: 25.
6. Oppo O, Demetris AJ, Raikow RB, Randhawa PS. Human polyoma virus infection of renal allografts: Histopathologic diagnosis, clinical significance, and literature review. Mod Pathol 1996; 9: 105.
7. Nickeleit V, Hirsch HH, Binet IF, et al. Polyomavirus infection of renal allograft recipients: From latent infection to manifest disease. J AmSoc Nephrol 1999; 10: 1080.
8. Randhawa PS, Finkelstein S, Scantlebury V, et al. Human polyomavirusassociated interstitial nephritis in the allograft kidney. Transplantation 1999; 67: 103.
9. Mathur VS, Olson JL, Darragh TM, et al. Polyomavirus-induced interstitial nephritis in two renal transplant recipients: Case reports and review of the literature. Am J Kidney Dis 1997; 29: 754.
10. Purighalla R, Shapiro R, McCauley J, et al. BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis 1995; 26: 671.
11. Mylonakis E, Goes N, Rubin RH, et al. BK virus in solid organ transplant recipients: An emerging syndrome. Transplantation 2001; 72: 1587.
12. Hogan TF, Borden EC, McBain JA, et al. Human polyomavirus infections with JC virus and BK virus in renal transplant patients. Ann Intern Med 1980; 92: 373.
13. Binet I, Nickeleit V, Hirsch HH, et al. Polyomavirus disease under new immunosuppressive drugs: A cause of renal graft dysfunction and graft loss. Transplantation 1999; 67: 918.
14. Mckenzie EF, Poulding JM, Harrison PR, et al. Human polyoma virus (HPV) - A significant pathology in renal transplantation. Proc Eur Dial Transplant Assoc 1978; 15: 352.
15. Gardner SD, Mackenzie EF, Smith C, et al. Prospective study of human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J Clin Pathol 1984; 37: 578.
16. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal transplant patient. N Engl J Med 2002; 347: 488.
17. Nickeleit V, Klimkait T, Binet IF, et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342: 1309.
18. Ramos E, Drachenberg CG, Papadimitriou JC, et al. Clinical course of polyomavirus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13: 2145.
19. Ramos E, Drachenberg CG, Portocarrero M, et al. BK virus nephropathy diagnosis and treatment: Experience at the University of Maryland Renal Transplant Program. Clin Transpl 2003: 143.
20. Colvin RB, Mauiyyedi S. Differential diagnosis between infection and rejection in renal allografts. Transplant Proc 2001; 33: 1778.
21. Fishman JA. BK virus nephropathy-polyomavirus adding insult to injury. N Engl J Med 2002; 347: 527.
22. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3: 611.
23. Randhawa PS, Demetris AJ. Nephropathy due to polyomavirus type BK. N Engl J Med 2000; 342: 1361.
24. Drachenberg CB, Hirsch HH, Papadimitriou JC, et al. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: A prospective evaluation. Transplantation 2007; 84: 323.
25. Fink JC, Wiland AM, Rochussen JR, et al. The increased incidence of BK polyoma virus in renal transplant recipients treated with Prograf [abstract]. Transplantation 2000; 69: S385.
26. Koukoulaki M, Grispou E, Pistolas D, et al. Prospective monitoring of BK virus replication in renal transplant recipients. Transpl Infect Dis 2009; 11: 1.
27. Agha I, Alvarez A, Lopez-Rocafort L, et al. A prospective evaluation of BK virus infection in renal transplant patients [abstract]. Am J Transplant 2002; 2(suppl 3): 260.
28. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporin and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582.
29. Haririan A, Hamze O, Drachenberg C, et al. Polyomavirus reactivation in native kidney of pancreas alone allograft recipients. Transplantation 2003; 75: 1186.
30. Mengel M, Marwedel M, Radermacher J, et al. Incidence of polyomavirus-nephropathy in renal allografts: Influence of modern immunosuppressive drugs. Nephrol Dial Transplant 2003; 18: 1190.
31. Cosio F, Am H, Grande J, et al. Comparison of low versus high tacrolimus levels in kidney transplantation: Assessment of efficacy by protocol biopsy. Transplantation 2007; 83: 411.
32. Dadhania D, Snopkowski C, Ding R, et al. Epidemiology of BK virus in renal allograft recipients: Independent risk factors for BK virus replication. Transplantation 2008; 86: 521.
33. Acott P, O'Regan PA, Crocker JF. Suppression of early and chronic BK polyoma virus replication by mycophenolic acid in Vero cells. Transpl Int 2009; 22: 225.
34. Trofe J, Cavallo T, First M, et al. Polyomavirus in kidney and kidney pancreas transplantation: A define protocol for immunosuppression reduction and histological monitoring. Transplant Proc 2002; 34: 1788.
35. Trofe J, Gaber LW, Stratta RJ, et al. Polyomavirus in kidney and kidney-pancreas transplant recipients. Transpl Infect Dis 2003; 5: 21.